Next Article in Journal
Discovering Host Genes Involved in the Infection by the Tomato Yellow Leaf Curl Virus Complex and in the Establishment of Resistance to the Virus Using Tobacco Rattle Virus-based Post Transcriptional Gene Silencing
Next Article in Special Issue
Suppression of Coronavirus Replication by Cyclophilin Inhibitors
Previous Article in Journal
Hepatitis C Virus-Induced Mitochondrial Dysfunctions
Previous Article in Special Issue
Insights into the Roles of Cyclophilin A During Influenza Virus Infection
Open AccessArticle

Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms

1
Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla 92037, California, USA
2
Southern Research Institute, Frederick, Maryland 21701, USA
3
Debiopharm SA, Forum “après-demain”, Chemin Messidor 5-7, Case postale 5911, CH-1002 Lausanne, Switzerland
4
Klinisches Institut fuer Virologie, Medizinische Universitaet Wien, 1095 Vienna, Austria
*
Author to whom correspondence should be addressed.
Viruses 2013, 5(3), 981-997; https://doi.org/10.3390/v5030981
Received: 1 March 2013 / Revised: 18 March 2013 / Accepted: 20 March 2013 / Published: 22 March 2013
(This article belongs to the Special Issue Cyclophilins and Viruses)
DEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical HIV-1 isolates in vitro and decreases HIV-1 virus load in the majority of patients. HIV-1 isolates being naturally resistant to DEB025 have been detected in vitro and in nonresponder patients. By sequence analysis of their capsid protein (CA) region, two amino acid polymorphisms that correlated with DEB025 resistance were identified: H87Q and I91N, both located in the CypA-binding loop of the CA protein of HIV-1. The H87Q change was by far more abundant than I91N. Additional polymorphisms in the CypA-binding loop (positions 86, 91 and 96), as well as in the N-terminal loop of CA were detected in resistant isolates and are assumed to contribute to the degree of resistance. These amino acid changes may modulate the conformation of the CypA-binding loop of CA in such a way that binding and/or isomerase function of CypA are no longer necessary for virus replication. The resistant HIV-1 isolates thus are CypA-independent. View Full-Text
Keywords: DEB025; alisporivir; cyclophilin inhibitors; cyclosporines; HIV/retroviruses; HIV capsid; natural resistance DEB025; alisporivir; cyclophilin inhibitors; cyclosporines; HIV/retroviruses; HIV capsid; natural resistance
Show Figures

Figure 1

MDPI and ACS Style

Gallay, P.A.; Ptak, R.G.; Bobardt, M.D.; Dumont, J.-M.; Vuagniaux, G.; Rosenwirth, B. Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms. Viruses 2013, 5, 981-997.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop